{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":16,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":16,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6b4bed8a19df","filters":{"venue":"Biotechnology Law Report"}},"results":[{"id":"W2974520714","doi":"10.1089/blr.2019.29135.rbk","title":"Disharmonization in the Regulation of Transgenic Plants in Europe","year":2019,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Conestoga College","funders":"","keywords":"Parliament; European union; Member state; Legislation; Political science; Legislature; Member states; European commission; State (computer science); Genetically modified organism; Commission; Law; Public administration; Biotechnology; Business; International trade; Biology; Politics","authors":[{"name":"Ramesh Bikram Karky","is_ca":true},{"name":"Mark Perry","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02205585330586195,"gpt":0.2312997247597048,"spread":0.2092438714538429,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00563867,0.0003294776,0.0003322953,0.0009117233,0.001717612,0.003456014,0.001419496,0.007583317,0.001880404],"category_scores_gemma":[0.00387108,0.0003225312,0.00109423,0.0005885146,0.003058219,0.001305352,0.001924269,0.003575179,0.0002850124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002597988,"about_ca_system_score_gemma":0.001983899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01593342,"about_ca_topic_score_gemma":0.01240936,"domain_scores_codex":[0.9954139,0.0006424058,0.0003226227,0.001218998,0.001593539,0.00080848],"domain_scores_gemma":[0.9968241,0.001813733,0.0003309003,0.0004543835,0.0004074231,0.0001692879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002645185,0.0002438128,0.004641911,0.0001485584,0.00008465379,0.001297694,0.001714238,0.002881779,0.102626,0.8263699,0.008325723,0.05140133],"study_design_scores_gemma":[0.0002644074,0.001548162,0.06464359,0.0005591097,0.0005127275,0.002811618,0.001920323,0.01046409,0.1976143,0.1711771,0.5480623,0.0004223941],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.5260209,0.006220127,0.03776432,0.01401471,0.0006846138,0.0002227333,0.0003864635,0.0005369001,0.4141492],"genre_scores_gemma":[0.9189638,0.001638683,0.007193997,0.009241636,0.0001006909,0.0001523244,0.0001917017,0.00007669593,0.06244044],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01593342,"threshold_uncertainty_score":0.03168136,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2608488164","doi":"10.1089/blr.2016.29030.mk","title":"A Decade of Data Protection for Innovative Drugs in Canada: Issues, Limitations, and Time for a Reassessment","year":2016,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"CARE Canada","funders":"","keywords":"Intellectual property; Scope (computer science); Investment (military); Data Protection Act 1998; Treaty; Promotion (chess); Business; Welfare; Investment protection; International trade; Political science; International investment; Law; Foreign direct investment","authors":[{"name":"Megan Kendall","is_ca":true},{"name":"Declan Hamill","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06956880997068911,"gpt":0.3430112295530542,"spread":0.2734424195823651,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09520661,0.0008436261,0.002067256,0.005695601,0.01842376,0.03076342,0.007088907,0.01809328,0.003956982],"category_scores_gemma":[0.1323688,0.001263429,0.002211504,0.008372334,0.03907398,0.01668854,0.007033079,0.04058532,0.000796635],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2011521,"about_ca_system_score_gemma":0.5629376,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9614477,"about_ca_topic_score_gemma":0.9659117,"domain_scores_codex":[0.8954917,0.0124204,0.005453719,0.006054338,0.06964096,0.01093885],"domain_scores_gemma":[0.7116358,0.09904348,0.009500514,0.009542129,0.1409137,0.02936435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009865045,0.00008817721,0.003427942,0.001312692,0.0001062906,0.0004819143,0.006515735,0.0005633198,0.0006120065,0.3575594,0.5165148,0.112719],"study_design_scores_gemma":[0.00004263548,0.0000446917,0.004742658,0.003219245,0.00006964018,0.0001765258,0.004061218,0.0003106509,0.0004360649,0.02083109,0.9659018,0.0001637763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.002487289,0.04794749,0.00134896,0.9316602,0.004190416,0.00004072956,0.0004305344,0.00006230603,0.01183204],"genre_scores_gemma":[0.07976375,0.08756874,0.008105675,0.8062022,0.003953924,0.00009548127,0.0006553011,0.0001716075,0.01348332],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.7988479,"threshold_uncertainty_score":0.9265504,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967718889","doi":"10.1089/blr.2004.23.556","title":"Patenting of \"Higher Life Forms\" in Canada","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; European union; Political science; Library science; Law; Biology; Business; International trade","authors":[{"name":"Adrian Zahl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02110794340125666,"gpt":0.2190713244917879,"spread":0.1979633810905313,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002771871,0.0003087163,0.000515743,0.003286102,0.01091982,0.007070892,0.001956576,0.005401497,0.008407077],"category_scores_gemma":[0.009685197,0.0005524434,0.0007542177,0.00297047,0.003187731,0.00166874,0.001375715,0.003955193,0.0004623108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08139713,"about_ca_system_score_gemma":0.1943334,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9923361,"about_ca_topic_score_gemma":0.9954671,"domain_scores_codex":[0.9937895,0.0002234014,0.0002068641,0.000461004,0.003433645,0.001885584],"domain_scores_gemma":[0.9897079,0.002857128,0.0003855778,0.0004221197,0.005136165,0.00149117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004187466,0.0002701094,0.01596734,0.0005438196,0.00007634791,0.001392727,0.004700004,0.002229977,0.00852173,0.6387156,0.1971299,0.1300338],"study_design_scores_gemma":[0.0001530032,0.0002177713,0.07703735,0.0002580739,0.0001029414,0.0002361886,0.001747419,0.002309591,0.006253265,0.01098891,0.900536,0.000159561],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.2512853,0.01019588,0.0033017,0.06278846,0.001567777,0.0005103031,0.003582808,0.0003949643,0.6663728],"genre_scores_gemma":[0.5595511,0.005905579,0.002730289,0.01600627,0.0002410822,0.0001157784,0.001184846,0.00007746585,0.4141878],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.08139713,"threshold_uncertainty_score":0.5905803,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4251060970","doi":"10.1089/0730031041724837","title":"Schmeiser <i>v.</i> Monsanto Canada Inc.,","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; Statutory law; Law; Statutory interpretation; Political science; Computer science; World Wide Web","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04458843433448383,"gpt":0.19539434234246,"spread":0.1508059080079762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001756541,0.0007298569,0.0003604661,0.001804356,0.01656675,0.007449342,0.00228929,0.01294883,0.02605637],"category_scores_gemma":[0.006084583,0.0007714464,0.0007678238,0.001543177,0.00203683,0.002206826,0.001466315,0.008507408,0.006086149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01779344,"about_ca_system_score_gemma":0.05103108,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8462131,"about_ca_topic_score_gemma":0.9524292,"domain_scores_codex":[0.9965089,0.0001565702,0.00008634046,0.0002888046,0.001554213,0.001405217],"domain_scores_gemma":[0.9967895,0.000843855,0.0001048205,0.00007704442,0.001830212,0.0003546319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006573398,0.00003900464,0.002852116,0.00009375045,0.0000143815,0.0004292387,0.0008624223,0.0001628852,0.0009676539,0.07169832,0.9098964,0.01291805],"study_design_scores_gemma":[0.00003813142,0.00002874035,0.007199162,0.0001566688,0.00005074035,0.0001467279,0.001560241,0.0003825649,0.001719035,0.00577772,0.982868,0.00007236521],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0151865,0.00710533,0.001184326,0.1846396,0.002182039,0.0002066794,0.00305671,0.0004662538,0.7859725],"genre_scores_gemma":[0.07526373,0.002941106,0.001080472,0.2103181,0.00036529,0.000136685,0.001052272,0.0001367577,0.7087055],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1537869,"threshold_uncertainty_score":0.3093851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243854610","doi":"10.1089/blr.2012.9659","title":"Canada May Not Approve Generic Versions of OxyContin","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; Volume (thermodynamics); Political science; Library science; Computer science; World Wide Web; Physics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.08033790925893307,"gpt":0.20725504633266,"spread":0.1269171370737269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004143817,0.000440163,0.0004329752,0.001431953,0.004341794,0.003767912,0.002660719,0.007841545,0.02754182],"category_scores_gemma":[0.01125533,0.000581405,0.001179776,0.001305214,0.002295939,0.001661533,0.001185074,0.004059166,0.004819104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01276409,"about_ca_system_score_gemma":0.02914009,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4978233,"about_ca_topic_score_gemma":0.6377397,"domain_scores_codex":[0.9956717,0.0002892621,0.0001873315,0.0003917061,0.002440351,0.001019668],"domain_scores_gemma":[0.9893818,0.002651235,0.0004880148,0.001559879,0.005289544,0.0006295171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009464475,0.0002706053,0.0117949,0.0004081407,0.0001067522,0.001531852,0.001377659,0.0006760254,0.009948995,0.1908725,0.6812136,0.1008525],"study_design_scores_gemma":[0.0001530039,0.0001821422,0.01616113,0.000198115,0.0001052851,0.0005147025,0.0003563647,0.0005839244,0.004064724,0.004413453,0.9731973,0.00006973284],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.06593583,0.002585013,0.003791687,0.0297667,0.002128297,0.000690834,0.004386928,0.002147169,0.8885675],"genre_scores_gemma":[0.315858,0.001684714,0.004610191,0.05503571,0.00071032,0.0002672776,0.003012835,0.0004651248,0.6183558],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.5021766,"threshold_uncertainty_score":0.9898514,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029144942","doi":"10.1089/blr.2013.9911","title":"The Pharmaceutical/Biopharmaceutical Landscape—Traversing Canada's Patent and Regulatory Regimes","year":2013,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biopharmaceutical; Traverse; Patent law; Download; Intellectual property; Political science; Law; Biotechnology; Biology; Geography; Computer science; Cartography","authors":[{"name":"By Daphne Lainson","is_ca":false},{"name":"Nancy Pei","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07683336325037865,"gpt":0.2268990146442865,"spread":0.1500656513939078,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01130228,0.0004617172,0.0007285192,0.005177657,0.03476874,0.03043709,0.003232879,0.01695313,0.008938301],"category_scores_gemma":[0.01933352,0.0008410569,0.001153038,0.0051072,0.02013876,0.007311871,0.004718165,0.01503366,0.0006015558],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1880899,"about_ca_system_score_gemma":0.3907479,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9874742,"about_ca_topic_score_gemma":0.9947259,"domain_scores_codex":[0.9775141,0.001549144,0.0005166014,0.001471799,0.01309757,0.005850796],"domain_scores_gemma":[0.9678113,0.008533381,0.001263433,0.001019272,0.01440889,0.006963723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006418214,0.00009424748,0.003149438,0.0001255299,0.00002823676,0.0003921494,0.002567207,0.0006073709,0.001089089,0.8122969,0.1334697,0.04611591],"study_design_scores_gemma":[0.00007621297,0.0000773916,0.0200924,0.0006717077,0.00007285628,0.0001789604,0.005012906,0.001401289,0.001157642,0.0836701,0.887367,0.0002215993],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.04597992,0.01398469,0.002235732,0.5685013,0.001404328,0.0001212268,0.0006938495,0.0001521828,0.3669267],"genre_scores_gemma":[0.5785026,0.01422569,0.005293218,0.2602032,0.001094977,0.00009208403,0.0002870525,0.0001917421,0.1401093],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.81191,"threshold_uncertainty_score":0.9417006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249687475","doi":"10.1089/blr.2007.9911","title":"PTO Agrees to Review Patents on Anti-HIV Drug; Canadian Decision May or May Not Have Profound Implications; PTO Strives to Get a Handle on <i>Markush</i> Claim; CAFC Agrees Patent Law Preempts D.C. Price-Control Measure","year":2007,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Patent law; Law; Control (management); Political science; Law and economics; Business; Economics; Medicine; Virology; Intellectual property; Management","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.084812807088495,"gpt":0.3132504497636691,"spread":0.2284376426751741,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006193644,0.0004849314,0.001442595,0.001819398,0.01265696,0.008650252,0.003310174,0.02936069,0.05251686],"category_scores_gemma":[0.02741913,0.0008479289,0.001923267,0.002283276,0.00274847,0.003338287,0.001603536,0.01426646,0.0209371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02034661,"about_ca_system_score_gemma":0.06962698,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4801849,"about_ca_topic_score_gemma":0.6693404,"domain_scores_codex":[0.9877689,0.0004990047,0.0004403659,0.001084619,0.007096458,0.003110501],"domain_scores_gemma":[0.9767346,0.004775369,0.0007198493,0.001298644,0.01344139,0.003030261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001104621,0.00006648377,0.00111905,0.00006232226,0.00002814018,0.0003476611,0.0001943364,0.00008829745,0.0009276271,0.05317517,0.9340856,0.009794846],"study_design_scores_gemma":[0.00006141919,0.0000437905,0.003506765,0.00006997495,0.00006327283,0.0001920552,0.00021871,0.00045363,0.001822744,0.004897344,0.9885911,0.00007916825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.006071235,0.001282533,0.001788521,0.3397746,0.00727137,0.0003504222,0.003314459,0.0006437154,0.6395031],"genre_scores_gemma":[0.057952,0.0008441504,0.002932918,0.2158679,0.002167314,0.0001552404,0.0009741075,0.0002351541,0.7188711],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.5198151,"threshold_uncertainty_score":0.9547799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246441873","doi":"10.1089/blr.2009.9923","title":"FDA Cannot Write Definitions on Its Own; APHIS Releases Biotechnology Quality Management System; Environmental Impact Statement Needed for Alfalfa; EU Finds Monsanto Corn Safe; High-Oleic Soybeans Okayed; Farmer Irritated with Biotechnology Opponents; Canada Drops Canola Complaint Against WTO; Cambridge to Ban Level 4 Laboratories; Restriction on Use of Antibiotics in Animal Field; Eight-Feature Corn Gets U.S., Canadian Approval","year":2009,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Aphis; Canola; Agricultural science; Biotechnology; Business; Biology; Agronomy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0538544858823115,"gpt":0.2573817806383774,"spread":0.2035272947560658,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01007667,0.001091605,0.001151039,0.003194761,0.005188037,0.009771462,0.003954307,0.009158923,0.06471442],"category_scores_gemma":[0.03325324,0.001075902,0.001417346,0.003745435,0.003490237,0.007068727,0.002453415,0.009206729,0.08630452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005450916,"about_ca_system_score_gemma":0.01346979,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02225085,"about_ca_topic_score_gemma":0.02388333,"domain_scores_codex":[0.9819871,0.003117664,0.001536936,0.001298725,0.0105187,0.001540912],"domain_scores_gemma":[0.9529327,0.01024113,0.002718875,0.004519868,0.02837716,0.001210407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002333437,0.00004307874,0.0001741233,0.0001498868,0.000003709497,0.0000492723,0.0001970778,0.00005388628,0.0008154718,0.06663556,0.9058366,0.02601801],"study_design_scores_gemma":[0.000007687448,0.00001646753,0.0001886247,0.0001245345,0.000003981238,0.00004592791,0.00008146388,0.00003377832,0.0002771031,0.003674664,0.9955356,0.00001032672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0008880874,0.003057509,0.0118667,0.03628551,0.006574386,0.0005383588,0.004882678,0.001508594,0.9343982],"genre_scores_gemma":[0.02294748,0.005965628,0.02359495,0.1193362,0.003560879,0.002512691,0.01636033,0.001985864,0.803736],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9777492,"threshold_uncertainty_score":0.2164913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214559639","doi":"10.1089/blr.2008.9935","title":"Third Circuit Accepts Preemption Arguments; More Cautions About Follow-On Biologics; Health Canada Issues Approval Guidance; FDA Takes First Steps in Expanding Drug Safety; Congress Proposes Requiring “Country of Origin” Statement; Congress Wants Direct Treatment Comparisons; Further Congressional Questions About Drug Advertising; Promised Studies Not Done; Warning over Avandia; Inspections of Foreign Facilities Will Not Be Easy; FDA Guidance on Genomics Term Definitions; European Scientists Want More Nanotechnology Regulation; Geron Stem Cell Trial on Hold; South Korea Clarifies Cloning Regulations; Decisions Needed on Antivirals in Advance of Flu Epidemic; Efforts to Control Genetic Testing; Bush Signs Genetic Information Nondiscrimination Act; Drug Companies Petition for Looser Restrictions on Literature on Off-Label Uses; Merck Said to Have Violated Publishing Ethics; Trade in Biotechnology Requires Closer Control; U.N. Alleges Chinese Dissidents Being Used as Organ Sources; Recent Approvals; Approval Delays?; NIH's Open Access Policy Still Has Publishers Roiled; Tilting at the FDA","year":2008,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Preemption; Drug control; Federal preemption; Law; Medicine; Political science; Statute; Computer science","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1494701298097443,"gpt":0.3359656712391812,"spread":0.1864955414294369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007838882,0.001097722,0.001385971,0.001946908,0.01700295,0.01608806,0.004474525,0.05781,0.02102344],"category_scores_gemma":[0.0349744,0.001046392,0.003449615,0.001914088,0.006298506,0.007683945,0.002657066,0.03161863,0.007855016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01147795,"about_ca_system_score_gemma":0.01954313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1471663,"about_ca_topic_score_gemma":0.1955335,"domain_scores_codex":[0.9898953,0.001070603,0.0005759315,0.001435835,0.004517978,0.002504387],"domain_scores_gemma":[0.9775518,0.01333588,0.0005104296,0.0008866173,0.006908793,0.0008065759],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006133592,0.00006761508,0.0006158265,0.00005111648,0.00001800738,0.0003050115,0.0006041748,0.0001438949,0.0003773159,0.4381671,0.5528845,0.006704004],"study_design_scores_gemma":[0.0001452856,0.00007116818,0.001538975,0.0002118312,0.0001310763,0.0001850005,0.0005933058,0.000823458,0.00132159,0.06569674,0.929163,0.0001186432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.004615912,0.001526654,0.003432046,0.5635001,0.007727633,0.0001257548,0.00100481,0.000522733,0.4175443],"genre_scores_gemma":[0.05474761,0.0007767573,0.004040034,0.7384337,0.003900962,0.0003426387,0.0002519987,0.0002251735,0.1972811],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.9921611,"threshold_uncertainty_score":0.2926194,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3172086909","doi":"10.1089/blr.2021.29236.mg","title":"The EPO Guidelines They Are a-Changin’","year":2021,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quest University Canada","funders":"","keywords":"European patent office; German; Convention; Law; Patent application; Political science; Medicine; Business; Library science; Computer science; History","authors":[{"name":"Benjamin Quest","is_ca":false},{"name":"DR. Markus Grammel","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1541552739653997,"gpt":0.2621810474744923,"spread":0.1080257735090927,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007200527,0.0004986126,0.0006238781,0.00204971,0.003803775,0.01052135,0.002145882,0.01513116,0.04843445],"category_scores_gemma":[0.03138347,0.0007616876,0.0009219451,0.001615354,0.002468051,0.003651248,0.002520764,0.01148711,0.02671656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00345754,"about_ca_system_score_gemma":0.01276222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03599804,"about_ca_topic_score_gemma":0.06498781,"domain_scores_codex":[0.9906394,0.001452159,0.0006454194,0.0008395283,0.005060914,0.001362609],"domain_scores_gemma":[0.9865298,0.003611171,0.0005577006,0.001744854,0.006922204,0.0006342035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001920514,0.00006012787,0.0002608089,0.0000483721,0.000005341942,0.0001006877,0.0002418086,0.00008606096,0.0002782149,0.1211622,0.8581846,0.01955263],"study_design_scores_gemma":[0.00000998695,0.000007192933,0.0005005592,0.00006433752,0.000005007011,0.00003755345,0.00009363205,0.00007995404,0.0002610229,0.006653633,0.9922753,0.0000118072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.002343588,0.001319405,0.007379542,0.1138141,0.01870401,0.0004512088,0.002214024,0.0009596385,0.8528144],"genre_scores_gemma":[0.0122314,0.0007794623,0.007270773,0.1101869,0.002883707,0.0004019913,0.001063394,0.0005076929,0.8646746],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.04843445,"threshold_uncertainty_score":0.1620294,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031108337","doi":"10.1089/blr.2012.9750","title":"Securities Fraud Class Action Lawsuits Against Life Science Companies on the Rise in the First Quarter 2012","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Legal Education and Practice Innovations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Class action; Quarter (Canadian coin); Action (physics); Class (philosophy); Business; Law; Securities fraud; Political science; History; State (computer science); Computer science; Supreme court","authors":[{"name":"By David Kotler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06849701425227893,"gpt":0.367051030329021,"spread":0.2985540160767421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006031029,0.0004772566,0.0006704786,0.002832226,0.006855504,0.00790277,0.001281819,0.02181554,0.008867214],"category_scores_gemma":[0.0246101,0.0007131341,0.0009069222,0.001711499,0.001733497,0.00262189,0.002489397,0.01324543,0.002267326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007451292,"about_ca_system_score_gemma":0.009289945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04866785,"about_ca_topic_score_gemma":0.08200296,"domain_scores_codex":[0.9919322,0.0007167074,0.0003982953,0.0005779734,0.003825519,0.002549361],"domain_scores_gemma":[0.9811295,0.007593258,0.003542239,0.000746074,0.004290433,0.00269852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0005561631,0.0009576934,0.04977789,0.0001753411,0.0001346211,0.002007382,0.003855294,0.0005081522,0.003563953,0.1081954,0.7585198,0.07174838],"study_design_scores_gemma":[0.0004028341,0.0006571852,0.1681241,0.0006136591,0.0003739161,0.0011305,0.004189423,0.004596491,0.01493842,0.01185812,0.7928578,0.0002576303],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3450797,0.004838008,0.001757273,0.3873067,0.004393687,0.0003538593,0.002954044,0.0005646013,0.2527521],"genre_scores_gemma":[0.6163384,0.002016732,0.0007603682,0.1281499,0.00256053,0.0001995967,0.001288039,0.0000776949,0.2486087],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.04866785,"threshold_uncertainty_score":0.09676915,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039505100","doi":"10.1089/blr.2011.9983","title":"Expansion of the Canadian Research Exemption for Biotechnology Research Tools","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; Library science; Experimental biology; Political science; Sociology; Law; Biology; Computer science; World Wide Web; Computational biology","authors":[{"name":"Rebecca Goulding","is_ca":false},{"name":"Matthew R. Voell","is_ca":false},{"name":"Emily Marden","is_ca":false},{"name":"Ed Levy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5336590373403922,"gpt":0.3447900543510486,"spread":0.1888689829893436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01989707,0.001167725,0.001177414,0.009760168,0.01728443,0.01449575,0.007287208,0.01880283,0.01395831],"category_scores_gemma":[0.04462401,0.001545986,0.002968596,0.004162137,0.006633093,0.003404565,0.005604411,0.0148254,0.003581116],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.09407589,"about_ca_system_score_gemma":0.295475,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9519538,"about_ca_topic_score_gemma":0.9720435,"domain_scores_codex":[0.9397637,0.002387604,0.0017576,0.003699064,0.04257907,0.009812969],"domain_scores_gemma":[0.9307673,0.0123273,0.001472709,0.005387262,0.04299534,0.007050036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002172844,0.0002056763,0.003905082,0.000302274,0.00006608776,0.0008340019,0.002060368,0.001309996,0.007460973,0.5790118,0.3499632,0.05466329],"study_design_scores_gemma":[0.0001509667,0.00009856551,0.01798573,0.0004090818,0.0001247879,0.0003590968,0.0007704456,0.001654222,0.003458763,0.01427637,0.9605014,0.0002105325],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.0282713,0.002212124,0.007872982,0.0800299,0.003362988,0.0009908669,0.003369781,0.0009280005,0.872962],"genre_scores_gemma":[0.2917307,0.002227861,0.02377235,0.1093178,0.001461081,0.0008060961,0.002357996,0.0003760217,0.5679501],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9059241,"threshold_uncertainty_score":0.6825715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234058516","doi":"10.1089/blr.2010.9960","title":"In the High Court of Justice Before The Hon. Mr. Justice Arnold: <i>Intervet UK Ltd. v. Merial, the Queen's University of Belfast, and the University of Saskatchewan</i> (Case no. HC09C00779)","year":2010,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Conflict of Laws and Jurisdiction","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Queen (butterfly); Economic Justice; Law; Sociology; Biology; Political science; Botany","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.006586631673614615,"gpt":0.2323855653623284,"spread":0.2257989336887137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00370105,0.0005252623,0.0009694559,0.0007995333,0.02653173,0.01068901,0.002552796,0.02741453,0.01878018],"category_scores_gemma":[0.01598029,0.0009467815,0.001069979,0.0009095693,0.003773089,0.003676004,0.00404305,0.02848117,0.004686309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01014998,"about_ca_system_score_gemma":0.01495971,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1979518,"about_ca_topic_score_gemma":0.435894,"domain_scores_codex":[0.9940661,0.0005351221,0.0002881175,0.0009103069,0.001623172,0.002577188],"domain_scores_gemma":[0.9957487,0.002105923,0.0001387154,0.0001583884,0.001013881,0.0008344658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004887824,0.00004199206,0.001080295,0.00004500054,0.00002107132,0.001470994,0.00243542,0.00006521273,0.0005695598,0.1315513,0.8563915,0.006278805],"study_design_scores_gemma":[0.00004206089,0.000034266,0.00325931,0.0002264657,0.00006828718,0.0004855714,0.00528823,0.0002761472,0.001238319,0.02691806,0.9620621,0.0001011791],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.01946944,0.004402921,0.001317132,0.681043,0.01685914,0.0001641957,0.00079185,0.0001642689,0.275788],"genre_scores_gemma":[0.09651081,0.0009838574,0.0007838843,0.5120934,0.002163407,0.0001364443,0.0001947014,0.000127096,0.3870064],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.8020482,"threshold_uncertainty_score":0.3935991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234700261","doi":"10.1089/blr.2012.9649","title":"Canada Cancels Pfizer's Viagra Patent","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Patent law; Download; Volume (thermodynamics); Political science; Business; Law; Intellectual property; Computer science; World Wide Web; Physics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01869433833570806,"gpt":0.2323175447619683,"spread":0.2136232064262603,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003992394,0.001046618,0.001399384,0.003093266,0.01002289,0.01230619,0.003811524,0.04353798,0.03341724],"category_scores_gemma":[0.01838005,0.00102405,0.002111563,0.001562065,0.002883183,0.002574996,0.002050025,0.01681023,0.01164117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03340741,"about_ca_system_score_gemma":0.1630539,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8129959,"about_ca_topic_score_gemma":0.9148347,"domain_scores_codex":[0.9859515,0.0002111291,0.0002308286,0.0006982057,0.009884958,0.003023205],"domain_scores_gemma":[0.9877957,0.002240613,0.0002318619,0.0004744349,0.007045668,0.002211709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006565578,0.00006549869,0.0005372303,0.0000355101,0.00002389536,0.0003619989,0.00008347177,0.00007989642,0.0004919429,0.03487653,0.9519931,0.01138519],"study_design_scores_gemma":[0.00006820748,0.00004558462,0.001623406,0.00005348726,0.00004141003,0.0001385281,0.000131125,0.0002742728,0.000690659,0.001698065,0.9952015,0.00003375723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.01100964,0.003626602,0.00152408,0.2985421,0.03120781,0.0005334576,0.003335799,0.001279915,0.6489407],"genre_scores_gemma":[0.03173123,0.001344582,0.0008424296,0.1253844,0.002606608,0.00007764449,0.0007256364,0.000238145,0.8370494],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1870041,"threshold_uncertainty_score":0.3762109,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239469862","doi":"10.1089/blr.2011.9992","title":"A Close Look at Non-Inferiority Trials; FDA Issues Guidance on Safety for Clinical Trials; Geron Human Embryonic Stem Cell Trial Starts; National Academy of Sciences Discusses Postmarketing Trials; Bone Marrow Stem Cell Trial Authorized in Israel; Canadian Company Asked to Submit Proposal on Brain Injury Treatment to DoD","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Clinical trial; Stem cell; Medicine; Embryonic stem cell; Internal medicine; Biology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.217967746319671,"gpt":0.4613964784922311,"spread":0.2434287321725601,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1637257,0.002359066,0.005347051,0.005626575,0.01050728,0.02594364,0.008588112,0.1724849,0.01363193],"category_scores_gemma":[0.3382676,0.003492396,0.005684934,0.003197453,0.03709602,0.019998,0.006708154,0.1163325,0.008709499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009991236,"about_ca_system_score_gemma":0.02584781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007515839,"about_ca_topic_score_gemma":0.02444393,"domain_scores_codex":[0.8208144,0.1156857,0.01605714,0.00864051,0.03427764,0.004524459],"domain_scores_gemma":[0.4085004,0.5370626,0.0104024,0.009132317,0.02671546,0.008186848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001115579,0.0001200896,0.0002628303,0.0007127041,0.00008681023,0.0006580118,0.001047791,0.0001829365,0.0004280894,0.1354759,0.830005,0.03090838],"study_design_scores_gemma":[0.0004003534,0.0001548164,0.0007412516,0.00320859,0.0001460909,0.001024145,0.0005206404,0.0003986549,0.0003577693,0.1514299,0.8414231,0.0001946526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.0002401026,0.01449717,0.005720434,0.9230056,0.01814133,0.0002457698,0.000110428,0.0001623567,0.03787675],"genre_scores_gemma":[0.003394141,0.003136857,0.006912202,0.9585859,0.0165586,0.0003149172,0.00003237166,0.000167982,0.01089696],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1724849,"threshold_uncertainty_score":0.8658747,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252964882","doi":"10.1089/blr.2006.25.389","title":"First Product from Transgenic Animal Cleared in Europe; Mab Associated with Brain Infection Allowed Back on Market; Should U.S. Approve Follow-On Biologics?; D.C. Court of Appeals Finds Constitutional Right to Unapproved Drugs; Participating in Efforts Against Counterfeiters; Specifications Issued for Veterinary Biologics and Biotechnology Products; Electronic Communications Are Desirable for Important Drug Information; Guidance for Antiviral Drug Development; Short Stories: New Indication for Remicade; Bone Stimulant Approved in Canada","year":2006,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Clearance; Product (mathematics); Supreme court; Medicine; Food and drug administration; Law; Political science; Pharmacology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0803028059876358,"gpt":0.2432839347296266,"spread":0.1629811287419908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006200984,0.0003809794,0.0002570777,0.001244824,0.001605927,0.001539317,0.0005869827,0.002558192,0.05177227],"category_scores_gemma":[0.001119701,0.0003112146,0.0004158444,0.0004299454,0.000917449,0.0005419754,0.0004251196,0.00193569,0.01090629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003215614,"about_ca_system_score_gemma":0.004567128,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05628832,"about_ca_topic_score_gemma":0.203482,"domain_scores_codex":[0.9995263,0.00002669925,0.00001047918,0.00004680237,0.0003050361,0.0000847066],"domain_scores_gemma":[0.9993944,0.0001142563,0.00005260123,0.00005923327,0.0002607127,0.0001186963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003573843,0.0002503761,0.002512553,0.0002576987,0.00003887905,0.001503755,0.0003430451,0.0001979534,0.04703433,0.05227821,0.7606055,0.1346203],"study_design_scores_gemma":[0.00006618477,0.00009543131,0.003097662,0.00007804215,0.00002137181,0.0005075571,0.00005052364,0.00009696455,0.008376987,0.001527282,0.9860686,0.00001332884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01410846,0.010587,0.006230764,0.01855734,0.002359439,0.0003805006,0.0046977,0.001675762,0.941403],"genre_scores_gemma":[0.08378611,0.004764364,0.006624137,0.0114692,0.0003259763,0.0001222392,0.002657933,0.0002996369,0.8899503],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9437117,"threshold_uncertainty_score":0.1731955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}